The role of the coagulation system in peripheral arterial disease: interactions with the Arterial Wall and its vascular microenvironment and implications for rational therapies
Individual results with any GLP-1 medication vary significantly
and AS from Bertin Pharma (Montigny-le-Bretonneux, France)
One important change is that they state, GLP-1 RA therapy may be continued preoperatively in patients without elevated risk of delayed gastric emptying. The risk factors they state include: escalation phase of dosing, higher dose, weekly dosing (as opposed to daily dosing), gastrointestinal symptoms (nausea, vomiting, abdominal pain, dyspepsia, constipation), and medical conditions that may cause delayed gastric emptying
While insulin is very effective at lowering blood sugar, it does not help with weight loss